Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AXICABTAGENE CILOLEUCEL Cause Infection? 142 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 142 reports of Infection have been filed in association with AXICABTAGENE CILOLEUCEL (YESCARTA). This represents 1.7% of all adverse event reports for AXICABTAGENE CILOLEUCEL.

142
Reports of Infection with AXICABTAGENE CILOLEUCEL
1.7%
of all AXICABTAGENE CILOLEUCEL reports
85
Deaths
66
Hospitalizations

How Dangerous Is Infection From AXICABTAGENE CILOLEUCEL?

Of the 142 reports, 85 (59.9%) resulted in death, 66 (46.5%) required hospitalization, and 21 (14.8%) were considered life-threatening.

Is Infection Listed in the Official Label?

Yes, Infection is listed as a known adverse reaction in the official FDA drug label for AXICABTAGENE CILOLEUCEL.

What Other Side Effects Does AXICABTAGENE CILOLEUCEL Cause?

Cytokine release syndrome (4,140) Immune effector cell-associated neurotoxicity syndrome (1,821) Neurotoxicity (1,327) Pyrexia (859) Death (756) Disease progression (745) Hypotension (398) Neutropenia (391) Confusional state (299) Encephalopathy (292)

What Other Drugs Cause Infection?

ADALIMUMAB (11,552) METHOTREXATE (10,406) ETANERCEPT (10,379) RITUXIMAB (9,575) ABATACEPT (7,821) TOCILIZUMAB (7,349) PREDNISONE (6,334) TOFACITINIB (6,332) INFLIXIMAB (6,122) CERTOLIZUMAB PEGOL (5,954)

Which AXICABTAGENE CILOLEUCEL Alternatives Have Lower Infection Risk?

AXICABTAGENE CILOLEUCEL vs AXITINIB AXICABTAGENE CILOLEUCEL vs AZACITIDINE AXICABTAGENE CILOLEUCEL vs AZATHIOPRINE AXICABTAGENE CILOLEUCEL vs AZD-1222 AXICABTAGENE CILOLEUCEL vs AZELAIC ACID

Related Pages

AXICABTAGENE CILOLEUCEL Full Profile All Infection Reports All Drugs Causing Infection AXICABTAGENE CILOLEUCEL Demographics